94 related articles for article (PubMed ID: 2225706)
1. Does alternate-day cloprednol therapy prevent bone loss? A longitudinal double-blind, controlled clinical study.
Medici TC; Rüegsegger P
Clin Pharmacol Ther; 1990 Oct; 48(4):455-66. PubMed ID: 2225706
[TBL] [Abstract][Full Text] [Related]
2. Cloprednol therapy in steroid-dependent asthma.
Shapiro GG; Tattoni DS; Kelley VC; Pierson WE; Dorsett CS; Bierman CW
Pediatrics; 1979 May; 63(5):747-53. PubMed ID: 440895
[TBL] [Abstract][Full Text] [Related]
3. A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort.
LoCascio V; Ballanti P; Milani S; Bertoldo F; LoCascio C; Zanolin EM; Bonucci E
Calcif Tissue Int; 1998 Mar; 62(3):199-204. PubMed ID: 9501951
[TBL] [Abstract][Full Text] [Related]
4. Long-term cloprednol use in chronic asthma.
Gavani UD; Hyde JS; Khurana S; Manaligod LM
JAMA; 1979 Dec; 242(24):2679-82. PubMed ID: 501863
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of cloprednol versus placebo in asthma.
Goodman DH
Ann Allergy; 1978 Jun; 40(6):376-80. PubMed ID: 352197
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
[TBL] [Abstract][Full Text] [Related]
7. Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: a prospective study for 18 months.
Wang WQ; Ip MS; Tsang KW; Lam KS
J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):445-50. PubMed ID: 9564795
[TBL] [Abstract][Full Text] [Related]
8. Short-term efficacy and side effects of cloprednol in children with asthma.
Ellis EF; Morris HG; Kiechel F; Pollock JD; Strand LJ
J Clin Pharmacol; 1979 Oct; 19(10):675-83. PubMed ID: 512064
[TBL] [Abstract][Full Text] [Related]
9. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
Gallagher JC; Kable WT; Goldgar D
Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
[TBL] [Abstract][Full Text] [Related]
10. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
[TBL] [Abstract][Full Text] [Related]
11. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
[TBL] [Abstract][Full Text] [Related]
12. Bone density in asthmatic patients taking inhaled corticosteroids: comparison of budesonide and beclomethasone dipropionate.
Packe GE; Robb O; Robins SP; Reid DM; Douglas JG
J R Coll Physicians Lond; 1996; 30(2):128-32. PubMed ID: 8709058
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of glucocorticoids on calcium absorption and bone mass.
Gennari C
Br J Rheumatol; 1993 May; 32 Suppl 2():11-4. PubMed ID: 8495275
[TBL] [Abstract][Full Text] [Related]
14. Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects.
Medici TC; Grebski E; Häcki M; Rüegsegger P; Maden C; Efthimiou J
Thorax; 2000 May; 55(5):375-82. PubMed ID: 10770818
[TBL] [Abstract][Full Text] [Related]
15. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.
Messina OD; Barreira JC; Zanchetta JR; Maldonado-Cocco JA; Bogado CE; Sebastián ON; Flores D; Riopedre AM; Redondo G; Lázaro A
J Rheumatol; 1992 Oct; 19(10):1520-6. PubMed ID: 1464862
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-induced bone loss: a neglected problem.
Lukert BP
Chest; 1994 Jun; 105(6):1640-1. PubMed ID: 8205853
[No Abstract] [Full Text] [Related]
17. Metabolic effects of cloprednol-a new systemic corticosteroid.
Ortega E; Rodriguez C; Strand LJ; Bessler S; Segre E
J Clin Pharmacol; 1976; 16(2-3):122-8. PubMed ID: 1254734
[TBL] [Abstract][Full Text] [Related]
18. Beclomethasone dipropionate inhaler: a review of its pharmacology, therapeutic value and adverse effects. I: Asthma.
Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
Drugs; 1975; 10(3):166-210. PubMed ID: 172309
[TBL] [Abstract][Full Text] [Related]
19. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study.
Laan RF; van Riel PL; van de Putte LB; van Erning LJ; van't Hof MA; Lemmens JA
Ann Intern Med; 1993 Nov; 119(10):963-8. PubMed ID: 8105737
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years.
Egan JJ; Maden C; Kalra S; Adams JE; Eastell R; Woodcock AA
Eur Respir J; 1999 Jun; 13(6):1267-75. PubMed ID: 10445600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
